Tempur-Pedic Reports First Quarter Earnings
LEXINGTON, Ky., April 16, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Tempur-Pedic International Inc. (NYSE: TPX), the leading manufacturer, marketer and distributor of premium mattresses and pillows worldwide, today announced financial results for the first quarter ended March 31, 2009. The Company also updated financial guidance for 2009.
FIRST QUARTER FINANCIAL SUMMARY
-- Earnings per share (EPS) were $0.18 per diluted share in the first quarter of 2009 as compared to $0.18 per diluted share in the first quarter of 2008. The Company reported net income of $13.3 million for the first quarter of 2009 as compared to net income of $13.5 million in the first quarter of 2008. Net income results for the first quarter of 2009 include a non-recurring $1.3 million tax charge resulting from a change to a foreign tax law.
-- Net sales declined 28% to $177.1 million in the first quarter of 2009 from $247.2 million in the first quarter of 2008. On a constant currency basis, net sales declined 24%. Net sales in the domestic segment declined 28%, while international segment net sales declined 29%. On a constant currency basis, international segment net sales declined 18%.
-- Mattress sales declined 29% globally. Mattress sales declined 29% in the domestic segment and 29% in the international segment. On a constant currency basis, international mattress sales declined 17%. Pillow sales declined 27% globally. Pillow sales declined 25% domestically and 29% internationally. On a constant currency basis, international pillow sales declined 20%.
-- Gross profit margin was 46.2% as compared to 43.7% in the first quarter of 2008. The gross profit margin increased as a result of lower commodity and transportation costs, improved efficiencies in manufacturing, and pricing actions taken during the quarter, partially offset by fixed cost de-leverage related to lower production volumes.
-- Operating profit margin was 14.6% as compared to 11.9% in the first quarter of 2008. Operating profit margin improvement resulted from the expansion in gross profit margin and lower operating expenses. The Company reduced operating expenses by $22.7 million to $56.0 million in the first quarter of 2009 from $78.7 million in the first quarter of 2008.
-- Reflecting the Company's continued focus on generating cash, the Company generated $26.0 million of operating cash flow in the first quarter of 2009 as compared to $24.6 million in the first quarter of 2008.
-- During the quarter, the Company reduced Total debt by $19.3 million to $400.0 million. As of March 31, 2009, the Company's ratio of Funded debt to EBITDA was 2.38 times, well within the covenant in its credit facility, which requires that this ratio not exceed 3.00 times. For additional information about EBITDA and Funded debt (which are non-GAAP measures), please refer to the reconciliation and other information included in the attached schedule.
Chief Executive Officer Mark Sarvary commented, "We executed well during the first quarter. We made solid progress on our long-term initiatives most notably our initiative to drive gross margins. An easing commodity environment and our productivity initiatives have generated substantial margin improvement despite lower volumes. Importantly, we continued to drive balance sheet improvement by paying down debt."
Chief Financial Officer Dale Williams commented, "Sales in the first quarter were modestly below our expectations. In the domestic segment, while sales were essentially flat to the fourth quarter run rate, we did not experience the normal seasonal lift. In the international segment, sales were down from the fourth quarter reflecting a weakened run rate. As visibility continues to be low, we have established our revised sales guidance assuming only a modest seasonal benefit to first quarter unit volumes. Accordingly, we continue to adjust our production plans and operating expenses. Our drive to expand margins has generated substantial benefit and we are confirming our prior EPS guidance. In addition, we continue to project we will remain in compliance with the covenants in our credit facility."
2009 Financial Guidance
The Company maintained its EPS guidance to range from $0.70 to $0.90 per diluted share, but reduced its net sales guidance to range from $700 million to $740 million. The Company noted its expectations are based on information available at the time of this release, and are subject to changing conditions, many of which are outside the Company's control.
Conference Call Information
Tempur-Pedic International will host a live conference call to discuss financial results today, April 16, 2009 at 5:00 p.m. Eastern Time. The dial-in number for the conference call is 888-430-8669. The call is also being webcast and can be accessed on the investor relations section of the Company's website, www.tempurpedic.com.
For those who cannot listen to the live broadcast, a telephone replay of the call will be available from April 16, 2009 at 8:00 p.m. Eastern Time through April 23, 2009. To listen to the replay, dial 888-203-1112, participant code 9148257.
This release contains "forward-looking statements," within the meaning of federal securities laws, which include information concerning one or more of the Company's plans, objectives, goals, strategies, and other information that is not historical information. When used in this release, the words "estimates," "expects," "anticipates," "projects," "plans," "intends," "believes," and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements include, without limitation, statements relating to the Company's plans to improve its balance sheet and margins and further improve financial flexibility and its business; its ability to maintain compliance with its credit facility covenants; the Company's initiatives to align costs with anticipated sales levels; and the Company's expectations regarding net sales and earnings per share for 2009. All forward looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct.
There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the Company's control, could cause actual results to differ materially from those expressed as forward-looking statements. These risk factors include general economic, financial and industry conditions, particularly in the retail sector, as well as consumer confidence and the availability of consumer financing; the Company's ability to reduce expenses to align with reduced sales levels; uncertainties arising from global events; the effects of changes in foreign exchange rates on the Company's reported earnings; consumer acceptance of the Company's products; industry competition; the efficiency and effectiveness of the Company's advertising campaigns and other marketing programs; the Company's ability to increase sales productivity within existing retail accounts and to further penetrate the US retail channel, including the timing of opening or expanding within large retail accounts; the Company's ability to address issues in certain underperforming international markets; the Company's ability to continuously improve and expand its product line, maintain efficient, timely and cost-effective production and delivery of its products, and manage its growth; changes in foreign tax rates, including the ability to utilize tax loss carry forwards; and rising commodity costs. Additional information concerning these and other risks and uncertainties are discussed in the Company's filings with the Securities and Exchange Commission, including without limitation the Company's annual report on Form 10-K under the headings "Special Note Regarding Forward-Looking Statements" and "Risk Factors." Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements for any reason, including to reflect events or circumstances after the date on which such statements are made or to reflect the occurrence of anticipated or unanticipated events or circumstances.
About the Company
Tempur-Pedic International Inc. (NYSE: TPX) manufactures and distributes mattresses and pillows made from its proprietary TEMPUR(R) pressure-relieving material. It is the worldwide leader in premium and specialty sleep. The Company is focused on developing, manufacturing and marketing advanced sleep surfaces that help improve the quality of life for people around the world. The Company's products are currently sold in over 70 countries under the TEMPUR(R) and Tempur-Pedic(R) brand names. World headquarters for Tempur-Pedic International is in Lexington, KY. For more information, visit http://www.tempurpedic.com or call 800-805-3635.
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES Condensed Consolidated Statements of Income (In thousands, except per common share amounts) Three Months Ended March 31, 2009 2008 Chg% Net sales $177,104 $247,222 (28%) Cost of sales 95,243 139,141 Gross profit 81,861 108,081 (24%) Selling and marketing expenses 33,872 53,163 General, administrative and other expenses 22,108 25,585 Operating income 25,881 29,333 (12%) Other income (expense), net: Interest expense, net (4,571) (7,691) Other income (expense), net 348 (1,019) Total other expense (4,223) (8,710) Income before income taxes 21,658 20,623 5% Income tax provision 8,320 7,109 Net income $13,338 $13,514 (1%) Earnings per common share: Basic $0.18 $0.18 Diluted $0.18 $0.18 Weighted average common shares outstanding: Basic 74,874 74,591 Diluted 74,959 75,188 TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES Condensed Consolidated Balance Sheets (In thousands) March 31, December 31, 2009 2008 Chg % ASSETS Current Assets: Cash and cash equivalents $21,127 $15,385 Accounts receivable, net 90,500 99,811 Inventories 60,791 60,497 Prepaid expenses and other current Assets 12,284 9,233 Deferred income taxes 16,475 11,888 Total Current Assets 201,177 196,814 2% Property, plant and equipment, net 178,016 185,843 Goodwill 192,339 192,569 Other intangible assets, net 66,328 66,823 Other non-current assets 4,058 4,482 Total Assets $641,918 $646,531 (1%) LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable $40,140 $41,355 Accrued expenses and other current liabilities 68,312 65,316 Income taxes payable 7,934 7,783 Total Current Liabilities 116,386 114,454 2% Long-term debt 400,000 419,341 Deferred income taxes 28,667 28,371 Other non-current liabilities 12,550 11,922 Total Liabilities 557,603 574,088 (3%) Total Stockholders' Equity 84,315 72,443 16% Total Liabilities and Stockholders' Equity $641,918 $646,531 (1%) TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES Condensed Consolidated Statements of Cash Flows (In thousands) Three Months Ended March 31, 2009 2008 CASH FLOWS FROM OPERATING ACTIVITIES: Net income $13,338 $13,514 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 7,727 8,334 Amortization of stock-based compensation 1,903 1,979 Amortization of deferred financing costs 172 185 Bad debt expense 2,233 985 Deferred income taxes (4,742) (1,158) Foreign currency adjustments (311) 1,156 Loss on sale of equipment and other -- 41 Changes in operating assets and liabilities 5,679 (451) Net cash provided by operating activities 25,999 24,585 CASH FLOWS FROM INVESTING ACTIVITIES: Purchases of property, plant and equipment (1,423) (2,793) Acquisition of business, net of cash acquired -- (1,498) Payments for other (218) (145) Net cash used by investing activities (1,641) (4,436) CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from long-term revolving credit facility 61,500 7,221 Repayments of long-term revolving credit facility (79,721) (12,233) Repayments of long-term debt -- (77) Proceeds from issuance of Common stock -- 498 Excess tax benefit from stock based compensation -- 323 Dividend paid to stockholders -- (5,965) Payments for other -- (14) Net cash used by financing activities (18,221) (10,247) NET EFFECT OF EXCHANGE RATE CHANGES ON CASH (395) 3,350 Increase in cash and cash equivalents 5,742 13,252 CASH AND CASH EQUIVALENTS, beginning of period 15,385 33,315 CASH AND CASH EQUIVALENTS, end of period $21,127 $46,567
Summary of Channel Sales
The Company generates sales through four distribution channels: retail, direct, healthcare and third party. The retail channel sells to furniture and bedding retailers, specialty stores, and department stores, among others. The direct channel sells directly to consumers. The healthcare channel sells to hospitals, nursing homes, healthcare professionals and medical retailers. The third party channel sells to distributors in countries where Tempur-Pedic International does not operate its own distribution company.
The following table highlights net sales information, by channel and by segment, for the first quarter of 2009 compared to 2008:
(In thousands) CONSOLIDATED DOMESTIC INTERNATIONAL Three Months Ended Three Months Ended Three Months Ended March 31, March 31, March 31, 2009 2008 2009 2008 2009 2008 Retail $150,522 $207,903 $93,411 $129,120 $57,111 $78,783 Direct 9,729 12,744 8,478 10,675 1,251 2,069 Healthcare 8,902 12,257 2,694 3,822 6,208 8,435 Third Party 7,951 14,318 1,851 4,301 6,100 10,017 $177,104 $247,222 $106,434 $147,918 $70,670 $99,304
Summary of Product Sales
A summary of net sales by product is reported below:
(In thousands) CONSOLIDATED DOMESTIC INTERNATIONAL Three Months Ended Three Months Ended Three Months Ended March 31, March 31, March 31, 2009 2008 2009 2008 2009 2008 Mattresses $119,128 $168,050 $75,711 $106,872 $43,417 $61,178 Pillows 23,061 31,616 9,845 13,121 13,216 18,495 Other 34,915 47,556 20,878 27,925 14,037 19,631 $177,104 $247,222 $106,434 $147,918 $70,670 $99,304
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES EBITDA to Net Income and Funded debt to Total debt Non-GAAP Measures (In thousands)
The Company provides information regarding EBITDA and Funded debt which are not recognized terms under GAAP (Generally Accepted Accounting Principles) and do not purport to be alternatives to Net income as a measure of operating performance or Total debt. Because not all companies use identical calculations, these presentations may not be comparable to other similarly titled measures of other companies. A reconciliation of EBITDA to the Company's Net income and reconciliation of Funded debt to Total debt are provided below. Management believes that the use of EBITDA and Funded debt provides investors with useful information with respect to the terms of the Company's credit facility.
Reconciliation of EBITDA to Net income
The following table sets forth the reconciliation of the Company's reported Net income to the calculation of EBITDA for each of the three months ended June 30, 2008, September 30, 2008 , December 31, 2008 and March 31, 2009, as well as the twelve months ended March 31, 2009:
Three Months Twelve Months Ended Ended June 30, Sept. 30, Dec. 31, March 31, March 31, 2008 2008 2008 2009 2009 GAAP Net income $20,228 $ 24,071 $ 1,055 $13,338 $ 58,692 Plus: Interest expense 5,645 6,294 5,493 4,571 22,003 Income taxes 10,374 12,622 18,449 8,320 49,765 Depreciation & Amortization 10,413 10,222 9,849 9,630 40,114 EBITDA $46,660 $ 53,209 $34,846 $35,859 $ 170,574
Reconciliation of Funded debt to Total debt
The following table sets forth the reconciliation of the Company's reported Total debt to the calculation of Funded debt as of March 31, 2009:
As of March 31, 2009 GAAP basis Total debt $400,000 Plus: Letters of credit outstanding 5,573 Funded debt $405,573
Calculation of Funded debt to EBITDA
As of March 31, 2009 Funded debt $405,573 EBITDA 170,574 2.38 times
SOURCE Tempur-Pedic International Inc.
Copyright (C) 2009 PR Newswire. All rights reserved